Discrepancy in antimicrobial susceptibility test results obtained for oral streptococci with the Etest and agar dilution

Journal of Clinical Microbiology

Volumn 45, Issue 7, 2007, Pages 2162-2165

  Mokaddas, Eiman M ^a   Salako, Nathaneal O ^a   Philip, Leeba ^a   Rotimi, Vincent O ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ERYTHROMYCIN; IMIPENEM; PENICILLIN G; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DILUTION; FALSE POSITIVE RESULT; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SALIVARIUS;

ANTI-BACTERIAL AGENTS; CHILD; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH; RESEARCH DESIGN; STREPTOCOCCUS;

STREPTOCOCCUS MUTANS;

EID: 34547613505     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00063-07     Document Type: Article

References (20)

1. Amrouche, M. L., L. Schlegel, and A. Bouvet. 2004. Impact of susceptibility to antibiotics of streptococci and enterococci isolated from patients with infective endocarditis on antibiotic treatment. Ind. J. Med. Res. 119(Suppl.): 80-83.
2. Baker, C. N., S. A. Stocker, D. H. Culver, and C. Thornsberry. 1991. Comparison of the E-test to agar dilution, broth dilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J. Clin. Microbiol. 29:533-538.
3. Bancescu, G., S. Dumitriu, A. Bancesu, C. Defta, M. Pana, D. Ionescu, S. Alecu, and M. Zamfirescu. 2004. Susceptibility testing of Streptococcus mitis group isolates. Ind. J. Med. Res. 119(Suppl.):257-261.
4. Beighton, D., J. M. Hardie, and R. A. Whiley. 1991. A scheme for the identification of viridans streptococci. J. Med. Microbiol. 35:367-372.
5. Bonventura, G. D., E. Ricci, N. D. Loggia, G. Catamo, and R. Piccolomini. 1998. Evaluation of the E-test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization. J. Clin. Microbiol. 36:824-826.
6. Brown, D. F. J., and L. Brown. 1991. Evaluation of the E-test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother. 27:185-190.
7. Doern, G. V., M. J. Ferraro, A. B. Brueggemann, and K. L. Ruoff. 1996. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:891-894.
8. Hashemi, F. B., G. E. Schutze, and E. O. Mason, Jr. 1996. Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin. J. Clin. Microbiol. 34:1546-1547.
9. Jorgensen, J. H. 1993. Selection criteria for an antimicrobial susceptibility testing system. J. Clin. Microbiol. 31:2841-2844.
10. Macias, E. A., E. O. Mason, Jr., H. Y. Ocera, and M. T. Larocco. 1994. Comparison of E-test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J. Clin. Microbiol. 32:430-432.
11. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Informational supplement: approved standard M100-S12, p. 114-115. NCCLS, Wayne, PA.
12. Rosser, S. J., M. J. Alfa, S. Hoban, J. Kennedy, and G. K. Harding. 1999. E-test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci. J. Clin. Microbiol. 37:26-30.
13. Rotimi, V. O., N. O. Salako, E. M. Mokaddas, L. Philip, and P. Rajan. 2005. High frequency of isolation of antibiotic-resistant oral viridans streptococci from children in Kuwait. J. Chemother. 17:493-501.
14. Salako, N. O., V. O. Rotimi, S. M. Adib, and S. Al-Mutawa. 2004. Pattern of antibiotic prescription in the management of oral disease among dentists in Kuwait. J. Dent. 32:503-509.
15. Smith, A., M. S. Jackson, and H. Kennedy. 2004. Antimicrobial susceptibility of viridans group streptococci blood isolates to eight antimicrobial agents. Scand. J. Infect. Dis. 36:259-263.
16. Teng, L. J., P. R. Hsueh, Y. C. Chen, S. W. Ho, and K. T. Luh. 1998. Antimicrobial susceptibility of viridans streptococci in Taiwan with emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J. Antimicrob. Chemother. 41:621-627.
17. Tenover, F. C., C. N. Baker, and J. M. Swenson. 1996. Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae. J. Clin. Microbiol. 34:10-14.
18. Tenover, F. C., J. M. Swenson, C. M. O'Hara, and S. A. Stocker. 1995. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J. Clin. Microbiol. 33:1524-1527.
19. Thomas, J. P. 2003. Antihiotic resistance. Dent. Clin. N. Am. 47:623-639.
20. Wisplinnghoff, H., R. R. Reinert, O. Cornely, and H. Seifert. 1999. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J. Clin. Microbiol. 37: 1876-1880.